Aarhus University Seal / Aarhus Universitets segl

Jens Christian Jensenius

Curing human hybridomas infected with Mycoplasma hyorhinis

Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaperJournal articleResearchpeer-review

Tiamuline and minocycline were evaluated for the treatment of an IgM producing human-human hybridoma cell line infected with Mycoplasma hyorhinis. Tiamuline was used at a concentration of 10 micrograms/ml culture medium and minocycline at a concentration of 5 micrograms/ml culture medium. Both antibiotics were found to eliminate mycoplasma infection over a treatment period of 3 weeks, and the hybridoma cell line remained mycoplasma-free for 6 months after treatment. Tiamuline had no effect on either cell growth or IgM secretion. Whereas treatment with minocycline alternated the cell proliferation and completely inhibited IgM secretion. This effect on cell function was found to be reversible since both cell growth and IgM secretion returned to normal 1 week after the minocycline had been removed. Tiamuline as well as minocycline may be recommended for the treatment of human hybridomas infected with mycoplasma.
Original languageEnglish
JournalJournal of Immunological Methods
Pages (from-to)237-40
Number of pages4
Publication statusPublished - 1988

    Research areas

  • Cell Division, Cell Line, Diterpenes, Humans, Hybridomas, Immunoglobulin M, Minocycline, Mycoplasma, Tetracyclines

See relations at Aarhus University Citationformats

ID: 43923750